Defense Health Board; Notice of Federal Advisory Committee Meeting, 88744-88745 [2024-25940]

Download as PDF 88744 Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices well as related office visits, for adolescents and adults at increased risk of acquiring HIV, when provided to TRICARE Prime patients of by network providers to TRICARE Select patients, will be considered clinical preventive services not subject to cost-sharing. Digital Breast Tomosynthesis for Breast Cancer Screening as a Clinical Preventive Services Benefit: DHA will permanently cover digital breast tomosynthesis (DBT), also known as 3D mammography, as a clinical preventive services benefit not subject to costsharing. Provisional Coverage Changes Digital Breast Tomosynthesis for Breast Cancer Screening as a Clinical Preventive Services Benefit: Provisional Coverage of DBT for breast cancer screening, which spanned from January 1, 2020, to December 31, 2024, will lapse. However, as noted above, DHA will continue to cover DBT as a clinical preventive services benefit not subject to cost-sharing. Platelet-Rich Plasma for Major Joint Treatment and Rehabilitation: Plateletrich plasma (PRP) injections are excluded from coverage for all indications. The use of PRP for knee osteoarthritis and lateral elbow tendinopathy was covered under Provisional Coverage status from October 1, 2019, to September 30, 2024. Provisional Coverage of PRP lapsed on September 30, 2024, and will not be replaced with permanent coverage. Appendix A Certain TRICARE enrollee out-ofpocket costs (enrollment fees, premiums, catastrophic caps, deductibles, and copayments) are adjusted annually by federal law and regulations based on the annual Cost of Living Adjustment (COLA) applied to Uniformed Service member retired pay. A difference in copayments remains between those who joined a Uniformed Service before January 1, 2018, (Group A), and those who joined on or after that date (Group B). The retiree COLA is typically announced after the federal fiscal year begins in October. Beneficiary out-ofpocket expenses impacted by the 2025 COLA will be posted to the tricare.mil/ changes web page before the start of TRICARE Open Season, November 11, 2024. Premium Based Plans The CY 2025 monthly premiums for TRICARE Reserve Select, TRICARE Retired Reserve, and TRICARE Young Adult and the quarterly premiums for Continued Health Care Benefit Program will be posted to the tricare.mil/changes web page once announced. Pharmacy Out-of-Pocket Expenses for CY 2025 TRICARE Pharmacy copayments will remain unchanged on January 1, 2025: PHARMACY COPAYMENTS FOR CALENDAR YEAR 2025 * Year Retail network generic formulary 30-day supply Retail network brand-name formulary 30-day supply Retail network non-formulary 30-day supply Mail order generic formulary 90-day supply Mail order brand-name formulary 90-day supply Mail order Non-formulary 90-day supply 2025 ..................... $16 $43 $76 ** $13 $38 $76 * Active-duty Service members (ADSM) enjoy a $0 copay for covered drugs at any pharmacy. ** For all beneficiaries except ADSM, select brand-name maintenance medications (taken for long-term conditions) may only be filled twice at retail and then must be filled through home delivery or military pharmacy. Dated: November 5, 2024. Stephanie J. Bost, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–26066 Filed 11–7–24; 8:45 am] BILLING CODE 6001–FR–P DEPARTMENT OF DEFENSE Office of the Secretary Defense Health Board; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness (USD(P&R)), Department Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Defense Health Board (DHB) will take place. DATES: Open to the public Tuesday, November 19, 2024 from 9 a.m. to 12 p.m. eastern standard time (EST). ADDRESSES: The address of the open meeting is 8111 Gatehouse Rd, Room ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:38 Nov 07, 2024 Jkt 265001 345, Falls Church, VA 22042. The meeting will be held both in-person and virtually. To participate in the meeting, see the Meeting Accessibility section for instructions. FOR FURTHER INFORMATION CONTACT: CAPT Shawn Clausen, 703–275–6060 (voice), shawn.s.clausen.mil@health.mil (email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042. Website: https://www.health.mil/dhb. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of chapter 10 of title 5, United States Code (U.S.C.) (commonly known as the ‘‘Federal Advisory Committee Act’’ or ‘‘FACA’’), title 5, U.S.C. 552b (commonly known as the ‘‘Government in the Sunshine Act’’), and 41, Code of Federal Regulations (CFR), sections 102–3.140 and 102– 3.150. Due to circumstances beyond the control of the DoD, the DHB was unable to provide public notification required by 41 CFR 102–3.150(a) concerning its November 19, 2024 meeting. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Accordingly, the Advisory Committee Management Officer, for the Department of Defense, pursuant to 41 CFR 102– 3.150(b), waives the 15-calendar day notification requirement. Availability of Materials for the Meeting: Additional information, including the agenda, is available on the DHB website, https://www.health.mil/ dhb. A copy of the agenda or any updates to the agenda for the November 19, 2024, meeting will be available on the DHB website. Any other materials presented in the meeting may also be obtained at the meeting. Purpose of the Meeting: The DHB provides independent advice and recommendations to maximize the safety and quality of, as well as access to, health care for DoD health care beneficiaries. The purpose of the meeting is to provide progress updates on specific tasks before the DHB. Agenda: The DHB anticipates receiving an update on the Ethical Implementation of Artificial Intelligence (AI) in the Military Health System tasking and a briefing on essential questions and necessary elements of AI governance. E:\FR\FM\08NON1.SGM 08NON1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices Meeting Accessibility: Pursuant to 5 U.S.C. 552b and 41 CFR 102–3.140 through 102–3.165 and subject to the availability of space, this meeting will be held in-person and virtually and is open to the public from 9 a.m. to 12 p.m. on November 19, 2024, EST. Seating and virtual participation is limited and is on a first-come basis. All members of the public who wish to participate must register by emailing their name, rank/title, and organization/ company to dha.dhb@health.mil or by contacting Ms. Camille Gaviola at (703) 275–6047 no later than Thursday, November 14, 2024. Additional details will be required from all members of the public attending in-person that do not have Gatehouse building access. Once registered, participant access information will be provided. Special Accommodations: Individuals requiring special accommodations to access the public meeting should contact Ms. Camille Gaviola at least five (5) business days prior to the meeting so that appropriate arrangements can be made. Written Statements: Any member of the public wishing to provide comments to the DHB related to its current taskings or mission may do so at any time in accordance with section 10(a)(3) of the FACA, 41 CFR 102–3.105(j) and 102– 3.140, and the procedures described in this notice. Written statements may be submitted to the DHB’s Designated Federal Officer (DFO), CAPT Clausen, at shawn.s.clausen.mil@health.mil. Supporting documentation may also be included, to establish the appropriate historical context and to provide any necessary background information. If the written statement is not received at least five (5) business days prior to the meeting, the DFO may choose to postpone consideration of the statement until the next open meeting. The DFO will review all timely submissions with the DHB President and ensure they are provided to members of the DHB before the meeting that is subject to this notice. After reviewing the written comments, the President and the DFO may choose to invite the submitter to orally present their issue during an open portion of this meeting or at a future meeting. Dated: November 4, 2024. Stephanie J. Bost, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–25940 Filed 11–7–24; 8:45 am] BILLING CODE 6001–FR–P VerDate Sep<11>2014 17:38 Nov 07, 2024 Jkt 265001 DEPARTMENT OF DEFENSE Office of the Secretary Membership of the Performance Review Board Office of the Secretary of Defense (OSD), Department of Defense (DoD). ACTION: Notice of board membership. AGENCY: This notice announces the appointment of the DoD, OSD, Joint Staff, Defense Agencies, and DoD Field Activities, Performance Review Board (PRB) members, to include the U.S. Court of Appeals for the Armed Forces. The PRB shall provide fair and impartial review of Senior Executive Service and Senior Professional performance appraisals and make recommendations regarding performance ratings and performance awards to the Deputy Secretary of Defense. DATES: The board membership is applicable beginning on September 30, 2024. FOR FURTHER INFORMATION CONTACT: Ms. Laura E. Devlin Dominguez, Assistant Director for Office of the Secretary of Defense Senior Executive Management Office, Washington Headquarters Service, Department of Defense, (703) 693–8373. SUPPLEMENTARY INFORMATION: The publication of PRB membership is required by 5 United States Code (U.S.C.) 4314(c)(4). In accordance with 5 U.S.C. 4314(c)(4), the following executives are appointed to the OSD PRB with specific PRB panel assignments being made from this group. Executives listed will serve a one-year renewable term, beginning September 30, 2024. SUMMARY: Office of the Secretary of Defense Appointing Authority—Dr. Kathleen H. Hicks, Deputy Secretary of Defense Principal Executive Representative— Ms. Jennifer C. Walsh Chairperson—Mr. Kevin M. Mulvihill Robert P. Helfant Fredrick E. Carr Susan J. Goodyear John M. Tenaglia Serena Chan Sandra (Liz) E. Clark Brent C. Harvey Pamela M. Franceschi Raymond D. O’Toole, Jr. Robert E. Irie Krystyna M.A. Kolesar Jaques Reifman Jennifer L. Desautel David T. Beckwith Frm 00049 Fmt 4703 Keith E. Buchholz Leonard G. Litton Efstathia Fragogiannis Robert E. Thompson Leigh E. Method Christine M. Condon John E. Kreul Robert M. Brady Lewis Ratchford, Jr. Julia P. Sokol Juanita M. Christensen Christopher S. Argo John G. Fiore PRB Panel Members—Alternates Laura J. Gross David R. Kless Karen A. Schultheis Todd A. Srivcr Tina M. Pierce Shirley L. Reed Rosalie W. Tinsley William (Bill) G. Fitzhugh Lee A. Kelley Michael R. Odle Yvette S. Weber Mark S. Gorak Raju H. Shah Sudha Vyas Monica C. Williams Dated: November 5, 2024. Stephanie J. Bost, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–25985 Filed 11–7–24; 8:45 am] BILLING CODE 6001–FR–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DoD–2024–OS–0097] Submission for OMB Review; Comment Request Office of the Under Secretary of Defense for Acquisition and Sustainment (OUSD(A&S)), Department of Defense (DoD). ACTION: 30-Day information collection notice. AGENCY: The DoD has submitted to the Office of Management and Budget (OMB) for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act. DATES: Consideration will be given to all comments received by December 9, 2024. SUMMARY: PRB Panel Members PO 00000 88745 Sfmt 4703 Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular ADDRESSES: E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Pages 88744-88745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25940]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board; Notice of Federal Advisory Committee 
Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness 
(USD(P&R)), Department Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce that the 
following Federal Advisory Committee meeting of the Defense Health 
Board (DHB) will take place.

DATES: Open to the public Tuesday, November 19, 2024 from 9 a.m. to 12 
p.m. eastern standard time (EST).

ADDRESSES: The address of the open meeting is 8111 Gatehouse Rd, Room 
345, Falls Church, VA 22042. The meeting will be held both in-person 
and virtually. To participate in the meeting, see the Meeting 
Accessibility section for instructions.

FOR FURTHER INFORMATION CONTACT: CAPT Shawn Clausen, 703-275-6060 
(voice), shawn.s.clausen.mil@health.mil">shawn.s.clausen.mil@health.mil (email). Mailing address is 
7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042. 
Website: https://www.health.mil/dhb. The most up-to-date changes to the 
meeting agenda can be found on the website.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of chapter 10 of title 5, United States Code (U.S.C.) 
(commonly known as the ``Federal Advisory Committee Act'' or ``FACA''), 
title 5, U.S.C. 552b (commonly known as the ``Government in the 
Sunshine Act''), and 41, Code of Federal Regulations (CFR), sections 
102-3.140 and 102-3.150.
    Due to circumstances beyond the control of the DoD, the DHB was 
unable to provide public notification required by 41 CFR 102-3.150(a) 
concerning its November 19, 2024 meeting. Accordingly, the Advisory 
Committee Management Officer, for the Department of Defense, pursuant 
to 41 CFR 102-3.150(b), waives the 15-calendar day notification 
requirement.
    Availability of Materials for the Meeting: Additional information, 
including the agenda, is available on the DHB website, https://www.health.mil/dhb. A copy of the agenda or any updates to the agenda 
for the November 19, 2024, meeting will be available on the DHB 
website. Any other materials presented in the meeting may also be 
obtained at the meeting. Purpose of the Meeting: The DHB provides 
independent advice and recommendations to maximize the safety and 
quality of, as well as access to, health care for DoD health care 
beneficiaries. The purpose of the meeting is to provide progress 
updates on specific tasks before the DHB.
    Agenda: The DHB anticipates receiving an update on the Ethical 
Implementation of Artificial Intelligence (AI) in the Military Health 
System tasking and a briefing on essential questions and necessary 
elements of AI governance.

[[Page 88745]]

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b and 41 CFR 102-
3.140 through 102-3.165 and subject to the availability of space, this 
meeting will be held in-person and virtually and is open to the public 
from 9 a.m. to 12 p.m. on November 19, 2024, EST. Seating and virtual 
participation is limited and is on a first-come basis. All members of 
the public who wish to participate must register by emailing their 
name, rank/title, and organization/company to [email protected] or by 
contacting Ms. Camille Gaviola at (703) 275-6047 no later than 
Thursday, November 14, 2024. Additional details will be required from 
all members of the public attending in-person that do not have 
Gatehouse building access. Once registered, participant access 
information will be provided.
    Special Accommodations: Individuals requiring special 
accommodations to access the public meeting should contact Ms. Camille 
Gaviola at least five (5) business days prior to the meeting so that 
appropriate arrangements can be made.
    Written Statements: Any member of the public wishing to provide 
comments to the DHB related to its current taskings or mission may do 
so at any time in accordance with section 10(a)(3) of the FACA, 41 CFR 
102-3.105(j) and 102-3.140, and the procedures described in this 
notice. Written statements may be submitted to the DHB's Designated 
Federal Officer (DFO), CAPT Clausen, at shawn.s.clausen.mil@health.mil">shawn.s.clausen.mil@health.mil. 
Supporting documentation may also be included, to establish the 
appropriate historical context and to provide any necessary background 
information. If the written statement is not received at least five (5) 
business days prior to the meeting, the DFO may choose to postpone 
consideration of the statement until the next open meeting. The DFO 
will review all timely submissions with the DHB President and ensure 
they are provided to members of the DHB before the meeting that is 
subject to this notice. After reviewing the written comments, the 
President and the DFO may choose to invite the submitter to orally 
present their issue during an open portion of this meeting or at a 
future meeting.

    Dated: November 4, 2024.
Stephanie J. Bost,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-25940 Filed 11-7-24; 8:45 am]
BILLING CODE 6001-FR-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.